Medsafe approves first medicine using the ‘Rule of Two’ pathway

An evolving record of actual publisher reports and observed updates.

Loading your world… Followed reports appear in Following. Background push is still being tested.

New Zealand

First recorded 12/11/2026, 01:17:52. Last recorded 13/11/2026, 06:44:03.

Grouping is automated and may connect reports imperfectly. Publication times come from the publisher; “recorded” times show when OrbitalView observed them. This timeline does not reconstruct earlier developments.

Only one source report has been recorded so far. More developments will appear when the connected feeds publish related reporting.
  1. Recorded 12/11/2026, 01:17:52Source report

    Medsafe approves first medicine using the ‘Rule of Two’ pathway ↗

    Beehive · beehive.govt.nz · Official release · Beehive attributed reuse · Excerpt; formatting adapted.

    Paliperidone is the first medicine to be approved in New Zealand via the expedited ‘Rule of Two’ pathway, says Associate Health Minister David Seymour. “The ‘Rule of Two’ medicines approval pathway was introduced last year. It allows medicines to be approved within 30 days if the product has approval from two recognised overseas jurisdictions,” Mr Seymour says. The policy is starting with recognising medicine regulat

    Publisher RSS preview. Read the original for the full report and any subsequent corrections.

We display a correction label only when the publisher preview explicitly identifies one. A changed preview alone is an observed update, not evidence of a correction.